How our virtual‑first, hybrid model works

Wyndly delivers allergy care online first, then adds in‑person steps only when they’re clinically required. Most patients complete testing and start sublingual immunotherapy (SLIT) from home with 24/7 physician access, predictable pricing, and medication shipped direct. Typical improvement begins within 4–24 weeks, with long‑term immune change over ~3 years.

• At‑home, CLIA‑certified blood test for 40+ environmental allergens (pets, pollens, dust, mold), reviewed with a board‑certified doctor by video.

• Personalized SLIT plan: FDA‑approved tablets (for single allergens like specific grasses, ragweed, or dust mites) or multi‑allergen drops, with regular online follow‑ups.

• Transparent, subscription pricing and unlimited doctor support, including after‑hours on‑call coverage.

When we bring you in person

Some SLIT tablets require a supervised first dose and a brief observation period; after that, dosing continues at home. Wyndly coordinates this first visit in our office or a partner clinic where available.

• First tablet dose under medical supervision with 30‑minute observation (Grastek for timothy/grass, Ragwitek for ragweed, Odactra for dust mite).

• Partner‑clinic workflow is available in select markets; example: ADVENT offices start therapy in‑clinic before home dosing continues.

First‑dose coordination for tablets (what to expect)

1) Your Wyndly physician confirms the indication by test and history and prescribes your tablet. 2) We schedule your supervised first dose in a participating clinic. Bring current medication and medical history. 3) You’ll place the tablet under the tongue; staff monitor you for ≥30 minutes; no food/drink for 5 minutes afterward. 4) If tolerated, you’ll continue daily dosing at home and message your care team anytime for questions.

Epinephrine education and safety plan

• You’ll be prescribed an auto‑injectable epinephrine device for home use; we train you (and caregivers) on recognition of severe reactions and how to use it. Keep two devices available at all times while on tablet SLIT.

• Avoid starting tablet SLIT if you have severe or uncontrolled asthma, a history of severe systemic reaction to SLIT, EoE, or if you use beta‑blockers (which may blunt epinephrine response). Your Wyndly clinician will screen for these and advise alternatives.

Choosing your modality: drops vs. tablets (and when a visit is needed)

Step‑up path if your needs change

• Virtual‑only start (test → plan → home SLIT). If you later qualify for a tablet the care team coordinates the supervised first dose and transitions you seamlessly.

• If local access is limited, we help locate a partner site for first dosing; otherwise, you can remain on multi‑allergen drops without an in‑person visit.

Who is—and isn’t—a candidate for tablet SLIT

• Good candidates: confirmed IgE‑mediated sensitivity to product allergen; able to adhere to daily dosing and carry/use epinephrine.

• Not candidates (examples): severe/unstable asthma; history of severe SLIT reaction; known EoE; significant cardiovascular disease or medications that interfere with epinephrine (evaluate risks individually).

What this means for access and cost

• Virtual care keeps most visits at home; supervised first doses add a single, short clinic visit when tablets are used.

• Testing can be billed through insurance in many cases; ongoing treatment accepts HSA/FSA with transparent monthly pricing and a 90‑day money‑back guarantee if you don’t improve after starting treatment and completing check‑ins.

Quality and safety standards

• Wyndly clinicians follow major guideline evidence showing SLIT is effective for long‑term relief and that FDA‑labeled tablets require supervised first dosing with epinephrine education. Your plan is tailored to your history, triggers, and preferences.